abstract:Synaptic vesicle glycoprotein 2A is a ubiquitous synaptic vesicle protein that in humans is encoded by the SV2A gene. The protein is targeted by the anti-epileptic drug (AED) levetiracetam.
Levetiracetamisanantiepilepticdrug with novelantiepilepticmechanism, in which binding to SV2A, a synapticvesicleprotein, may result in itsanticonvulsant activity.